学术
摘 要:
目的：观察中心静脉导管引流后注药治疗恶性胸腔积液的临床疗效。方法：将恶性胸腔积液患者随机分成两组,分别进行中心静脉导管闭式引流（引流组）和常规胸腔穿刺（常规组）,并于胸腔内注入顺铂。结果：引流组胸腔积液的控制率为84.00%,明显优于常规组的57%（P〈0.01）,且不良反应少于常规组。结论：应用中心静脉导管装置引流恶性胸腔积液操作安全、简便,能最大限度地排净胸腔积液,对控制癌性胸腔积液有较好的疗效,能显著改善患者生活质量。[著者文摘]
文章出处:
《实用临床医学（江西）》-2007年8卷9期 -31-32页
栏目信息:
分 类 号:
文献标识码:
A
文章编号:
1009-8194（2007）09-0031-02
The Study of Small Bore Catheter Thoracostomy Closed Drainage Versus Conventional Pleural Aspiration in the Treatment of Malignant Pleural Effusions
PENG Chao-hua, XU Jun, LI Yun-hua （Department Of Respiratory Medicine,the First Hospital of Nanchang , Nanchang 330008, China）
Abstract:
Objective：To evaluate the efficacy of small bore catheter for drainage and administration of sclerosing agent in the treatment of malignant pleural effusions.Methods：Sixty patients with malignant pleural effusions were randomly assigned to small bore catheter thoracostomy closed drainage group or conventional pleural aspiration group.Cisplatin was infused into the thoracic cavity in eligible patients after drainage.Results：Over all response rate（complete response plus partial response） was 84.00% in small bore catheter thoracostomy closed drainage group and 57% in conventional pleural aspiration group respectively（P〈0.05）.And the side effects of small bore catheter thoracostomy closed drainage group were obviously less than that in conventional pleural aspiration group.Conclusion：Small bore intercostal catheter for drainage and administration of sclerosing agent is a valid and safe option for malignant pleural effusions.[著者文摘]
Key words:
malignant pleural effusion;small bore catheter;cisplatin
更多>>免费文章
cqvip.com